These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9636919)

  • 1. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration.
    Mets B; Michler RE; Delphin ED; Oz MC; Landry DW
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):326-9. PubMed ID: 9636919
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
    Gold J; Cullinane S; Chen J; Seo S; Oz MC; Oliver JA; Landry DW
    Am J Cardiol; 2000 Feb; 85(4):506-8, A11. PubMed ID: 10728962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive Transfusion Reaction Treated With Vasopressin in a Patient Taking an Angiotensin-Converting Enzyme Inhibitor: A Case Report.
    Pollard R; Boraski M; Block JG
    A A Case Rep; 2017 Jul; 9(1):4-8. PubMed ID: 28368902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
    Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and management of angiotensin-converting enzyme inhibitor-associated refractory hypotension during the perioperative period.
    Thoma A
    AANA J; 2013 Apr; 81(2):133-40. PubMed ID: 23971233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Vasopressin and Analogues to Treat Intraoperative Refractory Hypotension in Patients Prescribed Angiotensin-Converting Enzyme Inhibitors Undergoing General Anesthesia: A Systematic Review.
    Hedman KF; Mann CL; Spulecki C; Castner J
    AANA J; 2016 Dec; 84(6):413-419. PubMed ID: 28235174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
    Oster JR; Materson BJ
    Arch Intern Med; 1992 Apr; 152(4):704-10. PubMed ID: 1558426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is vasopressin really superior to norepinephrine in reversing milrinone-induced vasodilation?
    Lange M; Van Aken H; Westphal M
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):689. PubMed ID: 16939712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP; Elsner D; Riegger GA
    Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged refractory hypotension in cardiac surgery after institution of cardiopulmonary bypass.
    Pappalardo F; Landoni G; Franco A; Monaco C; Marino G; Torri G
    J Cardiothorac Vasc Anesth; 2002 Aug; 16(4):477-9. PubMed ID: 12154431
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass.
    Morales DL; Garrido MJ; Madigan JD; Helman DN; Faber J; Williams MR; Landry DW; Oz MC
    Ann Thorac Surg; 2003 Mar; 75(3):926-30. PubMed ID: 12645718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
    Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass.
    Overand PT; Teply JF
    Anesth Analg; 1998 Jun; 86(6):1207-9. PubMed ID: 9620504
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass.
    Oh YJ; Lee JH; Nam SB; Shim JK; Song JH; Kwak YL
    Br J Anaesth; 2006 Dec; 97(6):792-8. PubMed ID: 17032660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
    Saab G; Mindel G; Ewald G; Vijayan A
    Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
    Parwani P; Ryan J
    Circ Heart Fail; 2012 Nov; 5(6):819. PubMed ID: 23170021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.